Open Access

Knockdown of MIR9‑3HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR‑498 via EP300

  • Authors:
    • Fang Li
    • Ying Liang
    • Pian Ying
  • View Affiliations

  • Published online on: August 31, 2021     https://doi.org/10.3892/mmr.2021.12388
  • Article Number: 748
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cervical cancer is a serious gynecological cancer and one of the primary causes of mortality in female patients with cancer. Despite advances in cancer research, the molecular mechanism underlying cancer remains poorly understood. High levels of MIR9‑3 host gene (HG) are associated with the occurrence and development of cervical cancer. However, the specific role of MIR9‑3HG during the development of cervical cancer is unclear. In the present study, the expression of MIR9‑3HG was silenced in C33A and SiHa cervical cancer cell lines. Proliferation and apoptosis were measured in these cells using 5‑ethynyl‑2'‑deoxyuridine assay and flow cytometry, respectively. In addition, targeting microRNAs (miRs) of MIR9‑3HG and mRNAs of miR‑498 were predicted using public databases. The predicted interactions between these molecules were validated using RNA immunoprecipitation, RNA pull‑down and luciferase reporter assays. Lastly, C33A cells transfected with short hairpin MIR‑3HG alone or in combination with miR‑498 inhibitor or PC‑EP300 were subcutaneously injected into mice. The levels of miR‑498, EP300 and Ki67 in tumor tissue were measured via reverse transcription‑quantitative PCR or western blotting. MIR9‑3HG knockdown inhibited the proliferation of cervical cancer cells, whilst promoting apoptosis. MIR9‑3HG sponged miR‑498 and inhibited its expression. Additionally, miR‑498 interacted with EP300 and inhibited its expression. Transfection with miR‑498 inhibitor significantly decreased apoptosis levels; this effect was abolished following EP300 silencing in vitro. In vivo, both miR‑498 inhibition and EP300 overexpression reversed the inhibition of tumor growth mediated by MIR‑3HG knockdown. MIR9‑3HG promoted the proliferation cervical cancer cells via EP300 and miR‑498. These in vitro and in vivo findings demonstrate the regulatory role of the MIR9‑3HG/miR‑498/EP300 axis in cervical cancer cell growth. Thus, the present study identified novel molecular targets for the diagnosis and treatment of cervical cancer and provided new insight into the pathogenesis of cervical cancer.
View Figures
View References

Related Articles

Journal Cover

November-2021
Volume 24 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li F, Liang Y and Ying P: Knockdown of MIR9‑3HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR‑498 via EP300. Mol Med Rep 24: 748, 2021
APA
Li, F., Liang, Y., & Ying, P. (2021). Knockdown of MIR9‑3HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR‑498 via EP300. Molecular Medicine Reports, 24, 748. https://doi.org/10.3892/mmr.2021.12388
MLA
Li, F., Liang, Y., Ying, P."Knockdown of MIR9‑3HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR‑498 via EP300". Molecular Medicine Reports 24.5 (2021): 748.
Chicago
Li, F., Liang, Y., Ying, P."Knockdown of MIR9‑3HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR‑498 via EP300". Molecular Medicine Reports 24, no. 5 (2021): 748. https://doi.org/10.3892/mmr.2021.12388